
Helena Kosanovic
Examiner (ID: 5543, Phone: (571)272-9059 , Office: P/3749 )
| Most Active Art Unit | 3749 |
| Art Unit(s) | 3761, 3762, 3743, 3749 |
| Total Applications | 891 |
| Issued Applications | 401 |
| Pending Applications | 37 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20246880
[patent_doc_number] => 20250295749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => INACTIVATED STAPHYLOCOCCUS COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/863030
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18863030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/863030 | INACTIVATED STAPHYLOCOCCUS COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | May 4, 2023 | Pending |
Array
(
[id] => 19396164
[patent_doc_number] => 12070493
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-27
[patent_title] => Double auxotrophic mycobacterium and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/307998
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 22
[patent_no_of_words] => 6391
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307998
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307998 | Double auxotrophic mycobacterium and uses thereof | Apr 26, 2023 | Issued |
Array
(
[id] => 20248340
[patent_doc_number] => 20250297209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => PRODUCTION OF PROTEINS OF INTEREST IN A NON-SPORULATING BACTERIAL STRAIN
[patent_app_type] => utility
[patent_app_number] => 18/862275
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18862275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/862275 | PRODUCTION OF PROTEINS OF INTEREST IN A NON-SPORULATING BACTERIAL STRAIN | Apr 25, 2023 | Pending |
Array
(
[id] => 20788610
[patent_doc_number] => 12662515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => Fusion protein comprising BP26 and antigenic polypeptide
[patent_app_type] => utility
[patent_app_number] => 18/139003
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 42
[patent_no_of_words] => 11313
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18139003
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/139003 | FUSION PROTEIN COMPRISING BP26 AND ANTIGENIC POLYPEPTIDE | Apr 24, 2023 | Issued |
Array
(
[id] => 19120030
[patent_doc_number] => 11963991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Treatment of warts
[patent_app_type] => utility
[patent_app_number] => 18/304629
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 34060
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18304629
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/304629 | Treatment of warts | Apr 20, 2023 | Issued |
Array
(
[id] => 18565745
[patent_doc_number] => 20230256072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => COMPOSITIONS AND METHODS FOR VACCINATION AGAINST NEISSERIA GONORRHOEAE
[patent_app_type] => utility
[patent_app_number] => 18/305164
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305164 | COMPOSITIONS AND METHODS FOR VACCINATION AGAINST NEISSERIA GONORRHOEAE | Apr 20, 2023 | Abandoned |
Array
(
[id] => 18692599
[patent_doc_number] => 20230322907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/303453
[patent_app_country] => US
[patent_app_date] => 2023-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18303453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/303453 | Anti-PCRV antibodies that bind PCRV, compositions comprising anti-PCRV antibodies, and methods of use thereof | Apr 18, 2023 | Issued |
Array
(
[id] => 20192294
[patent_doc_number] => 20250269004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/857949
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18857949
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/857949 | ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOF | Apr 17, 2023 | Pending |
Array
(
[id] => 20093606
[patent_doc_number] => 20250223542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => MODIFIED MICROALGAE FOR ENHANCED PHOSPHATE UPTADE INVOLVING OVEREXPRESSION OF PSR1 AND OPTIONALLY UNDEREXPRESSION OF PTC1
[patent_app_type] => utility
[patent_app_number] => 18/853760
[patent_app_country] => US
[patent_app_date] => 2023-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18853760
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/853760 | MODIFIED MICROALGAE FOR ENHANCED PHOSPHATE UPTADE INVOLVING OVEREXPRESSION OF PSR1 AND OPTIONALLY UNDEREXPRESSION OF PTC1 | Apr 11, 2023 | Pending |
Array
(
[id] => 20083730
[patent_doc_number] => 20250213666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses
[patent_app_type] => utility
[patent_app_number] => 18/852553
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18852553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/852553 | Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses | Mar 30, 2023 | Pending |
Array
(
[id] => 20517648
[patent_doc_number] => 20260041751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-12
[patent_title] => FUSION PROTEIN AND VACCINE
[patent_app_type] => utility
[patent_app_number] => 18/852392
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18852392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/852392 | FUSION PROTEIN AND VACCINE | Mar 29, 2023 | Pending |
Array
(
[id] => 18646996
[patent_doc_number] => 20230292763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => COMPOSITION FOR CONTROLLING PLANT DISEASE AND INSECT AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 18/180321
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180321
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180321 | Composition for controlling plant disease and insect and method for preparing same | Mar 7, 2023 | Issued |
Array
(
[id] => 20336708
[patent_doc_number] => 20250340828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF LEUCINE AND/OR ISOLEUCINE
[patent_app_type] => utility
[patent_app_number] => 18/843159
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18843159
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/843159 | MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF LEUCINE AND/OR ISOLEUCINE | Feb 28, 2023 | Pending |
Array
(
[id] => 18467058
[patent_doc_number] => 20230201338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/169632
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169632
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169632 | Pneumococcal conjugate vaccine formulations | Feb 14, 2023 | Issued |
Array
(
[id] => 18449564
[patent_doc_number] => 20230190840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ENTERIC AEROBIZATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/109785
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109785
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/109785 | Enteric aerobization therapy | Feb 13, 2023 | Issued |
Array
(
[id] => 19763199
[patent_doc_number] => 12221472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Compositions and methods for the removal of biofilms
[patent_app_type] => utility
[patent_app_number] => 18/168824
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 37
[patent_no_of_words] => 58860
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168824
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168824 | Compositions and methods for the removal of biofilms | Feb 13, 2023 | Issued |
Array
(
[id] => 18860306
[patent_doc_number] => 20230414740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => IMMUNOGENIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/105791
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105791
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/105791 | IMMUNOGENIC COMPOSITIONS | Feb 2, 2023 | Pending |
Array
(
[id] => 20005981
[patent_doc_number] => 20250144203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => NANOSTRUCTURE-BASED VECTOR SYSTEM FOR BACTERIAL AND VIRAL ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 18/835724
[patent_app_country] => US
[patent_app_date] => 2023-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18835724
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/835724 | NANOSTRUCTURE-BASED VECTOR SYSTEM FOR BACTERIAL AND VIRAL ANTIGENS | Feb 1, 2023 | Pending |
Array
(
[id] => 19877866
[patent_doc_number] => 20250110123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => METHOD FOR DETECTING HELICOBACTER SUIS ANTIBODY USING WHOLE CELL
[patent_app_type] => utility
[patent_app_number] => 18/833175
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18833175
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/833175 | METHOD FOR DETECTING HELICOBACTER SUIS ANTIBODY USING WHOLE CELL | Jan 24, 2023 | Pending |
Array
(
[id] => 19172521
[patent_doc_number] => 20240158495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/153749
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153749 | Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses Thereof | Jan 11, 2023 | Abandoned |